Lunch Report: ASX Rallies Further On Positive COVID-19 Vaccine News

The Aussie market continues to hit fresh 8-month highs as the ASX 200 pushes through 6,400 points at lunch. Positive news about a Pfizer vaccine trial has seen travel, banking and energy stocks soar.